Background/Aims: Anorectal abscesses are most frequently based on a coexistent fistula in ano. Whether these should be searched for and excised initially or not remains controversial. Our aim was to determine which approach has less recurrences and carries a lower risk of continence disorders. Methods: 158 patients with an anorectal abscess or anal fistula were identified in our institution over a period of 75 consecutive months. The records and follow-up questionnaires of 131 patients were evaluable. The mean follow-up period was 40 (range 3–78) months. Results: When fistulotomy was performed at the time of draining the abscess, the recurrence rate could be reduced, in comparison to incision and drainage alone, from 34 to 4% (p = 0.007). In the group of patients undergoing surgery for a recurrence, the recurrence rate could even be reduced from 67 to 0% (p = 0.03) by simultaneous fistulotomy. A total of 4 of the 131 patients (3%) developed incontinence of liquid stool and flatus, but no incontinence of solid stool occurred. Incontinence did only occur after recurrent disease. Conclusions: The number of recurrences requiring surgery can be significantly reduced by initial fistulotomy. The risk to develop incontinence increases with recurrent anorectal disease, not with careful fistulotomy.

Keywords:
Anorectal abscess, Anorectal fistula, Fistulotomy
1.
Stelzner F: Die anorectalen Fisteln, ed 3. Berlin, Springer, 1981.
2.
Eisenhammer S: The final evaluation and classification of surgical treatment of the primary anorectal cryptoglandular intermuscular (intersphincteric) fistulous abscess and fistula. Dis Colon Rectum 1978;21:237–254.
3.
Schouten WR, van Vroonhoven TJ: Treatment of anorectal abscess with or without primary fistulectomy: Results of a prospective randomized trial. Dis Colon Rectum 1991;34:60–63.
4.
Tang CL, Chew SP, Seow-Choen F: Prospective randomized trial of drainage alone vs. drainage and fistulotomy for acute perianal abscesses with proven internal opening. Dis Colon Rectum 1996;39:1415–1417.
5.
Hämälainen KP, Sainio AP: Incidence of fistulas after drainage of acute anorectal abscesses. Dis Colon Rectum 1998;41:1357–1362.
6.
Fucini C: One stage treatment of anal abscesses and fistulae: A clinical appraisal on the basis of two different classifications. Int J Colorectal Dis 1991;6:12–16.
7.
Van Tets WF, Kuijpers JHC: Continence disorders after anal fistulotomy. Dis Colon Rectum 1994;37:1194–1197.
8.
Ho YH, Tan M, Chui CH, Leong A, Eu KW, Seow-Choen F: Randomized controlled trial of primary fistulotomy with drainage alone for perianal abscesses. Dis Colon Rectum 1997;40:1435–1438.
9.
Garcia-Aguilar J, Belmonte C, Wong WD, Goldberg SM, Madoff RD: Anal fistula surgery: Factors associated with recurrence and incontinence. Dis Colon Rectum 1996;39:723–729.
10.
Van Tets WF, Kuijpers JHC: Seton treatment of perianal fistula with high anal or rectal opening. Br J Surg 1995;82:895–897.
11.
Henrichsen S, Christiansen J: Incidence of fistula-in-ano complicating anorectal sepsis: A prospective study. Br J Surg 1986;73:371–372.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.